Functional and transcriptional analysis of embryonic hematopoietic stem cell development at the single cell level
Functional and transcriptional analysis of embryonic hematopoietic stem cell development at the single cell level
批准号:
10080103
负责人:
Brandon K Hadland
金额:
$9.29万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-08 至 2021-12-31
关键词:
AddressAdultAgonistAortaBasic ScienceBioinformaticsBiological AssayCell CommunicationCell-Free SystemCellsChildChild CareClinicalCoculture TechniquesCollaborationsDevelopmentDevelopment PlansDiseaseEmbryoEmbryonic DevelopmentEndothelial CellsEngineeringEngraftmentFred Hutchinson Cancer Research CenterGene Expression ProfileGene Expression ProfilingGenerationsGenetic TranscriptionGoalsGonadal structureHematological DiseaseHematologyHematopoieticHematopoietic Stem Cell TransplantationHematopoietic stem cellsHeterogeneityIL3 GeneImmobilizationImmune System DiseasesImmunologicsIn VitroIndividualInheritedInstitutesKnowledgeLaboratoriesLeadLigandsMediatingMentorsMentorshipMesonephric structureMethodsMolecularMolecular AnalysisPathway interactionsPediatric HospitalsPhenotypePhysiciansPluripotent Stem CellsPopulationProcessPropertyRegulator GenesResearchResourcesScientistSignal PathwaySignal TransductionSiteSorting - Cell MovementStem Cell DevelopmentStem cell transplantStromal CellsSystemTechniquesTestingTherapeuticTrainingTranslatingTransplantationUniversitiesWashingtonWorkbaseblastomere structurecareercareer developmentclinical applicationexperiencegene therapygenome sciencesgenome-widehematopoietic stem cell fatehematopoietic stem cell self-renewalhemogenic endotheliumimprovedin vivoindexinginnovative technologiesinsightinterestmachine learning algorithmmedical schoolsnew technologynotch proteinnovelprecursor cellresearch and developmentself-renewalsingle-cell RNA sequencingskillsstem cell biologystem cell nichestem cell therapystem cellssuccesstooltranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The therapeutic potential of hematopoietic stem cells (HSC) could be significantly enhanced by methods to
generate HSC de novo from pluripotent stem cells (PSC) or reprogrammed adult cells. Thus, there has been
great interest in understanding the embryologic origin of HSC and the signal pathways that guide HSC
development and self-renewal, such that the process of HSC genesis can be recapitulated in vitro, a goal
which has yet to be realized. Given the heterogeneity and developmental asynchrony in hemogenic precursors
during their emergence in the embryo, to achieve this it will be necessary to develop better strategies to isolate
and characterize the rare precursors capable of giving rise to HSC and to understand the signals that drive
their development to functional, engrafting HSC. To this end, I have established that endothelial cells (EC)
derived from the aorta-gonad-mesonephros region (AGM), the niche in which the first HSC emerge, can
promote the in vitro specification and self-renewal of engrafting HSC from hemogenic precursors, including
recent studies at the single cell level. Furthermore, I have shown that the Notch pathway functions in both
specification and self-renewal of HSC in the EC niche, and that use of immobilized Notch ligands to activate
the Notch pathway, along with hematopoietic cytokines, is sufficient to induce expansion of embryonic HSC.
Building upon this work, the goals of this proposal are to utilize this novel in vitro AGM-EC system to elucidate
the phenotypic, molecular, and functional properties of HSC precursors as they transition to functional HSC
capable of long-term, multilineage engraftment. This will require isolation and functional characterization of
HSC precursors across different stages of their development at the single cell level (Aim 1), followed by single
cell transcriptional analysis to determine the gene regulatory networks and molecular signals promoting their
development to functional HSC (Aim 2A). In studies working toward the engineering of stromal cell-free
systems for HSC generation, agonists of identified signaling pathways will be functionally tested for their
capacity to support HSC development in conjunction with the known requirement for Notch signaling activation
(Aim 2B). Altogether, these studies will provide novel insight into the unique properties of HSC
precursors, as well at the signaling mechanisms governing their maturation to functional HSC, which
will have important implications in advancing our ability to generate HSC from PSC.
To accomplish these aims, I will leverage the wealth of resources available in the mentoring laboratory of Dr.
Bernstein, as well as key resources available at the Fred Hutchinson Cancer Research Center, the University
of Washington, and Seattle Children’s Hospital, and opportunities for co-mentorship from Dr. Shahin Rafii at
the Ansary Stem Cell Institute at Weill Cornell Medical College. A key aspect of my career development plan is
to also acquire new skills that will facilitate my research objectives, including techniques in single cell RNA-seq
and bioinformatics analysis which will be performed in collaboration with and under the co-mentorship of Dr.
Cole Trapnell in Genome Sciences at the University of Washington. This type of interdisciplinary training will
provide me with the tools necessary to apply innovative technologies in unravelling the complexity of niche-
stem cell interactions that instruct HSC fates.
My research experience studying hematopoietic stem cell development has provided me with a strong
background to facilitate success in the proposed research goals. My clinical experience in caring for children
undergoing hematopoietic stem cell transplantation has cemented a strong passion to expand scientific
knowledge of HSC and translate this knowledge to improve therapies for children with hematologic,
immunologic, and oncologic diseases. Success in my research and career development goals outlined in this
proposal will enable me to establish an independent academic career as a physician-scientist with the skills to
lead a diverse research team and collaborate broadly to address essential questions in stem cell biology.
Ultimately, my long-term goal is to develop a laboratory-based career with focus on taking fundamental
principles discovered through basic research in developmental HSC biology toward clinical applications in
hematopoietic stem cell therapeutics.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
WNT5A from the fetal liver vascular niche supports human fetal liver hematopoiesis.
胎儿肝血管生态位的Wnt5a支持人类胎儿肝造血。
DOI:
10.1186/s13287-021-02380-z
发表时间:
2021-06-05
期刊:
Stem cell research & therapy
影响因子:
7.5
作者:
[Choi YJ, Heck AM, Hayes BJ, Lih D, Rayner SG, Hadland B, Zheng Y]
通讯作者:
Zheng Y
Dormancy-dependent determination of hematopoietic stem cell fate from hemogenic endothelium
-
批准号:10636527
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2023
-
负责人:Brandon K Hadland
-
依托单位:
海外基金